7 resultados para visceral manifestation

em Repositório Científico do Instituto Politécnico de Lisboa - Portugal


Relevância:

10.00% 10.00%

Publicador:

Resumo:

As leishmanioses são doenças causadas por protozoários do género Leishmania que são parasitas intracelulares obrigatórios das células fagocíticas. O objectivo deste estudo foi caracterizar a infecção por Leishmania infantum em murganhos BALB/c inoculados por via intradérmica, analisando a evolução do parasitismo e as respostas imunitárias desenvolvidas. A carga parasitária foi determinada por PCR em tempo real. Foram detectados parasitas desde o 7º dia pós-infecção, verificando-se a disseminação visceral do parasita ao 56º dia pós-infecção. Os linfócitos dos animais do grupo infectado proliferaram em resposta à estimulação antigénica, enquanto que os macrófagos peritoneais produziram nitritos na presença do antigénio. Estes resultados demonstraram que os murganhos BALB/c inoculados por via intradérmica constituem um bom modelo experimental de leishmaniose visceral.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

The deposition of amyloid fibers at the peripheral nervous system can induce motor neuropathy in Familial Amiloidotic Polyneuropethy (FAP) patients. This produces progressive reductions in functional capacity. The only treatment for FAP is a liver transplant, followed by aggressive medication that can affect patients' metabolism. To our knowledge, there are no data on body fat distribution or comparison between healthy and FAP subjects, which may be important for clinical assessment and management of this disease. PURPOSE: To analyze body fat content and distribution between FAP patients and healthy subjects. METHODS: Body fat content and distribution were measured through Double Energy X-ray Densitometry (DXA) in two groups. Group 1 consisted of 43 Familial Amyloidotic Polyneuropathy patients (19 males, 32 + 8 Yrs, and 24 females, 37 + 5 yrs), who had liver transplant less than 2 months before. Group 2 consisted of 18 healthy subjects of similar age (8 males, 36 + 7 yrs, and 10 females, 39 + 5 yrs). RESULTS: Healthy subjects showed higher values than FAP patients for: BMI (24,2+2,3kg/m2 vs 22,3+3,8 kg/m2 respectively, p<0,05), % trunk BF (26,21+8,34kg vs 20,78+9,05kg respectively, p<0,05), % visceral BF (24,43+7,97% vs 19,21+9,30% respectively, p<0,05), % abdominal BF (26,63+8,51% vs 20,63+10,35% respectively, p<0,05) abdominal subcutaneous BF (0,533+0,421kg vs 0,353+0,257kg respectively, p=0,05), abdominal BF/BF ratio (0,09+0,02 vs 0,08+0,02 respectively, p<0,05) and abdominal BF/trunk BF ratio (0,19+0,03 vs 0,17+0,03 respectively, p<0,05). CONCLUSIONS: These results showed that FAP patients soon after liver transplantation exhibited a healthier body fat profile compared to controls. However, fat content and distribution varied widely in FAP subjects, suggesting an individualized approach for assessment and intervention rather than general guidelines. Future research is needed to investigate the long term consequences on body fat following liver transplant in this population.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Here, we use Andreev reflection spectroscopy to study the spin polarization of high quality CrO2 films. We study the spin polarization as a function of growth temperature, resulting in grain size and electrical resistivity. In these films low temperature growth appears to be a necessary but not sufficient condition to guarantee the observation of high spin polarization, and this is only observed in conjunction with suppressed superconducting gap values and anomalously low interface properties. We suggest that this combination of observations is a manifestation of the long range spin triplet proximity effect. (C) 2007 American Institute of Physics.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Hyperhomocysteinemia (HHcy) is a risk factor for vascular disease, but the underlying mechanisms remain incompletely defined. Reduced bioavailability of nitric oxide (NO) is a principal manifestation of underlying endothelial dysfunction, which is an initial event in vascular disease. Inhibition of cellular methylation reactions by S-adenosylhomocysteine (AdoHcy), which accumulates during HHcy, has been suggested to contribute to vascular dysfunction. However, thus far, the effect of intracellular AdoHcy accumulation on NO bioavailability has not yet been fully substantiated by experimental evidence. The present study was carried out to evaluate whether disturbances in cellular methylation status affect NO production by cultured human endothelial cells. Here, we show that a hypomethylating environment, induced by the accumulation of AdoHcy, impairs NO production. Consistent with this finding, we observed decreased eNOS expression and activity, but, by contrast, enhanced NOS3 transcription. Taken together, our data support the existence of regulatory post-transcriptional mechanisms modulated by cellular methylation potential leading to impaired NO production by cultured human endothelial cells. As such, our conclusions may have implications for the HHcy-mediated reductions in NO bioavailability and endothelial dysfunction.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

In the literature, concepts of “polyneuropathy”, “peripheral neuropathy” and “neuropathy” are often mistakenly used as synonyms. Polyneuropathy is a specific term that refers to a relatively homogenous process that affects multiple peripheral nerves. Most of these tend to present as symmetric polyneuropathies that first manifest in the distal portions of the affected nerves. Many of these distal symmetric polyneuropathies are due to toxic-metabolic causes such as alcohol abuse and diabetes mellitus. Other distal symmetric polyneuropathies may result from an overproduction of substances that result in nerve pathology such as is observed in anti-MAG neuropathy and monoclonal gammopathy of undetermined significance. Other “overproduction” disorders are hereditary such as noted in the Portuguese type of familial amyloid polyneuropathy (FAP). FAP is a manifestation of a group of hereditary amyloidoses; an autosomal dominant, multisystemic disorder wherein the mutant amyloid precursor, transthyretin, is produced in excess primarily by the liver. The liver accounts for approximately 98% of all transthyretin production. FAP is confirmed by detecting a transthyretin variant with a methionine for valine substitution at position 30 [TTR (Met30)]. Familial Amyloidotic Polyneuropathy (FAP) – Portuguese type was first described by a Portuguese neurologist, Corino de Andrade in 1939 and published in 1951. Most persons with this disorder are descended from Portuguese sailors who sired offspring in various locations, primarily in Sweden, Japan and Mallorca. Their descendants emigrated worldwide such that this disorder has been reported in other countries as well. More than 2000 symptomatic cases have been reported in Portugal. FAP progresses rapidly with an average time course from symptom onset to multi-organ involvement and death between ten and twenty years. Treatments directed at removing this aberrant protein such as plasmapheresis and immunoadsorption proved to be unsuccessful. Liver transplantation has been the only effective solution as evidenced by almost 2000 liver transplants performed worldwide. A therapy for FAP with a novel agent, “Tafamidis” has shown some promise in ongoing phase III clinical trials. It is well recognized that regular physical activity of moderate intensity has a positive effect on physical fitness as gauged by body composition, aerobic capacity, muscular strength and endurance and flexibility. Physical fitness has been reported to result in the reduction of symptoms and lesser impairment when performing activities of daily living. Exercise has been advocated as part of a comprehensive approach to the treatment of chronic diseases. Therefore, this chapter concludes with a discussion of the role of exercise training on FAP.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Objectivos - Na sociedade atual as pessoas são diariamente expostas a inúmeras situações de stress. As exaltações vividas são transformadas em energia pulsional que por sua vez deve ser despendida segundo três vias: psíquica, motora e visceral. Se esta energia não for despendida pelas duas primeiras vias, acumula-se como carga psíquica originando tensão psíquica. A tensão gerada vai repercutir-se na saúde de cada indivíduo. Uma das causas da Coriorretinopatia Central Serosa (CRCS) é o stress. A CRCS é uma patologia de carácter esporádico, caracterizada por um descolamento seroso espontâneo da retina neuro sensorial na região macular, com consequente comprometimento da acuidade visual (AV). Sendo uma patologia de carácter esporádico desencadeada por situações de stress, pretende-se caracterizar as manifestações consequentes desta patologia, bem como abordar os factores diagnósticos da mesma, no caso em estudo. Metodologia - Estudo de caso. Análise de um paciente do sexo masculino, de 36 anos de idade, com diagnóstico de CRCS. Resultados - A CRCS caracteriza-se por um descolamento seroso da retina neuro sensorial na região macular, com comprometimento da visão. O paciente chegou à consulta com queixa de baixa de acuidade visual súbita do olho esquerdo. Realizaram-se exames para concluir o diagnóstico sendo estes, OCT, angiografia e avaliação da acuidade visual. Na angiografia verifica-se afeção da área macular, ao OCT verifica-se descolamento seroso da retina neuro sensorial na região macular. A acuidade visual era de 6/10 no olho esquerdo e 10/10 no olho direito. Apresentava ainda queixas de metamorfopsias. Discussão / Conclusão - Ainda que a etiologia da CRCS não seja totalmente conhecida, encontra-se associada a situações de stress, a hipertensão arterial, a comportamentos decorrentes da forma exagerada e ansiosa de viver, à competitividade, gravidez e medicação sistémica de esteróides. O tratamento inicial recomendado é repouso absoluto, caso se verifique insucesso o tratamento passará pela realização de terapia fotodinâmica.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Agência Financiadora: FCT - PTDC/QUI/72656/2006 ; SFRH/BPD/27454/2006; SFRH/BPD/44082/2008; SFRH/BPD/41138/2007